Radio
Now Playing
Quickyla Radio — Click to play
Open →
Radio
Now Playing Quickyla Radio — Click to play
Open Radio →
Breaking
First personalised cancer vaccine cuts risk of disease returning in major trial

Choose Language

Select a language for news translation.

Results for "Intismeran" 1 articles
First personalised cancer vaccine cuts risk of disease returning in major trial
🏥 Health
Intismeran vaccine reduces melanoma recurrence by 42% in major trial

A personalized mRNA cancer vaccine, Intismeran, reduced the risk of melanoma returning or causing death by 42% in a trial of 1,137 patients when combined with …

BBC Health 4 days ago 1
Markets
S&P 5005,432.18▲ 0.42%
NASDAQ17,891.40▲ 0.87%
DOW39,118.86▼ 0.15%
BTC$67,842▲ 2.14%
ETH$3,291▲ 1.38%
GOLD$2,341/oz▼ 0.31%
OIL (WTI)$82.14▲ 0.67%
EUR/USD1.0842▼ 0.09%
GBP/USD1.2641▲ 0.22%
NIKKEI38,471▲ 1.02%
FTSE 1008,218▼ 0.28%
Full Markets →
Local Weather
—°F
Local area
58% 12 mphH:78° L:61°
Emergency Alerts
No active alerts for your area right now.
AI Powered
Summarize any article instantly
Get 30-second summaries, bullet points, deep analysis, or a child-friendly version — powered by AI.
30-sec summary Bullet points Deep analysis
Based on Your Interests
Trending stories you might like
Sign in to personalize
Around the World
Video News
🏥 Health
4 days ago
Intismeran vaccine reduces melanoma recurrence by 42% in major trial
BBC Health · Watch
Religion & Culture More →
Islam Christianity Hinduism Judaism Sikhism Interfaith Culture

More to Read

First personalised cancer vaccine cuts risk of disease retu…
🏥 Health
Intismeran vaccine reduces melanoma recurrence by 42% in major trial
BBC Health · 4 days ago
Full view